Software

AI for digital pathology and spatial biology

Katana Labs GmbH

Katana Labs is a DeepTech and AI startup and combines extensive expertise in software engineering, machine learning, agentic AI, clinical research, oncology, digital pathology, and business. United by one mission, making chronic and complex diseases curable, Katana Labs believes in the power of multi-omics data to advance precision medicine. By leveraging cutting-edge software and pioneering AI technologies Katana Labs empowers subject matter experts, like researchers and clinical scientists, in their quest to decode biology and derive a much better understanding of the multidimensional data deeply embedded in tissue samples.

Made readily available through Katana Labs’ cloud-native AI platform Katana Edge, R&D teams can easily explore, analyze, and collaborate on to enhance workflow efficiency and productivity in life sciences, translational and clinical research as well as in the biopharma industry.

TGFS has been involved with the company since 2023.

Status
Active

Segment
Early stage

Headquarter
Dresden

Website
www.katana-labs.com

TGFS-Team
Sarah Schäfer
Martin Liebsch

Company news

New in the portfolio: Katana Labs GmbH

8. Nov. 2023

On the trail of cancer — the software from Katana Labs uses artificial intelligence to detect cancer cells. The TGFS invested in the Dresden-based company in the pre-seed phase so that the analysis software can be further developed, certified and used in laboratories worldwide.